Prime Medicine, Inc. Deferred Income Tax Expense (Benefit)
Prime Medicine, Inc. (PRME) reported Deferred Income Tax Expense (Benefit) of $0 for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2025-08-07
- Prime Medicine, Inc. deferred income tax expense (benefit) for the quarter ending 2025-06-30 was $0.00.
- Prime Medicine, Inc. deferred income tax expense (benefit) for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- Prime Medicine, Inc. deferred income tax expense (benefit) for the quarter ending 2024-12-31 was $0.00.
- Prime Medicine, Inc. deferred income tax expense (benefit) for the quarter ending 2024-09-30 was $0.00.
- Prime Medicine, Inc. deferred income tax expense (benefit) for fiscal 2024 was $0.00.
- Prime Medicine, Inc. deferred income tax expense (benefit) for fiscal 2023 was -$279.00K.
- Prime Medicine, Inc. deferred income tax expense (benefit) for fiscal 2022 was -$964.00K.
- Prime Medicine, Inc. deferred income tax expense (benefit) for fiscal 2021 was -$624.00K, a 133.42% decline from fiscal 2020.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $0.00 10-Q · filed 2025-08-07 | $0.00 derived: sum of 3 quarters · filed 2025-08-07 | $0.00 derived: sum of 4 quarters · filed 2025-08-07 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-08 | $0.00 derived: sum of 2 quarters · filed 2025-05-08 | $0.00 derived: sum of 3 quarters · filed 2025-05-08 | -$134.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $0.00 derived: sum of 2 quarters · filed 2025-02-28 | -$134.00K derived: sum of 3 quarters · filed 2025-08-07 | $0.00 10-K · filed 2025-02-28 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$134.00K derived: sum of 2 quarters · filed 2025-08-07 | $0.00 10-Q · filed 2024-11-12 | $0.00 derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-06-30 | -$134.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $0.00 10-Q · filed 2025-08-07 | $0.00 derived: sum of 3 quarters · filed 2025-08-07 | -$108.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $134.00K 10-Q · filed 2025-05-08 | $134.00K derived: sum of 2 quarters · filed 2025-05-08 | $26.00K derived: sum of 3 quarters · filed 2025-05-08 | $57.00K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$108.00K derived: sum of 2 quarters · filed 2025-02-28 | -$77.00K derived: sum of 3 quarters · filed 2025-02-28 | -$279.00K 10-K · filed 2025-02-28 |
| 2023-09-30 | -$108.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$77.00K derived: sum of 2 quarters · filed 2024-11-12 | -$279.00K 10-Q · filed 2024-11-12 | -$481.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $31.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$171.00K 10-Q · filed 2024-08-08 | -$373.00K derived: sum of 3 quarters · filed 2024-08-08 | -$161.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | -$202.00K 10-Q · filed 2024-05-10 | -$404.00K derived: sum of 2 quarters · filed 2024-05-10 | -$192.00K derived: sum of 3 quarters · filed 2024-05-10 | -$634.00K derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | -$202.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | $10.00K derived: sum of 2 quarters · filed 2024-03-01 | -$432.00K derived: sum of 3 quarters · filed 2024-03-01 | -$964.00K 10-K · filed 2024-03-01 |
| 2022-09-30 | $212.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | -$230.00K derived: sum of 2 quarters · filed 2023-11-03 | -$762.00K 10-Q · filed 2023-11-03 | $481.00K derived: sum of 4 quarters · filed 2023-11-03 |
| 2022-06-30 | -$442.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | -$974.00K 10-Q · filed 2023-08-07 | $269.00K derived: sum of 3 quarters · filed 2023-08-07 | |
| 2022-03-31 | -$532.00K 10-Q · filed 2023-05-11 | $711.00K derived: sum of 2 quarters · filed 2023-05-11 | ||
| 2021-12-31 | $1.24M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | -$624.00K 10-K · filed 2023-03-09 | ||
| 2021-09-30 | -$1.87M 10-Q · filed 2022-11-14 | |||
| 2020-12-31 | $1.87M 10-K · filed 2023-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B |